Indication

Biliary tract malignancy

Biliary tract malignancy refers to a heterogeneous group of aggressive epithelial cancers affecting the hepatobiliary ductal system, including intrahepatic and extrahepatic cholangiocarcinoma, gallbladder carcinoma, and ampulla of Vater carcinoma. Read more about Biliary tract malignancy

54 drugs 36 manufacturers

Advertisement

Drugs that treat it

Common Biliary tract malignancy therapies.

Showing 37–45 of 54 drugs

GEMCITABINE HCL

PYRIMIDINE ANALOGS·METASTATIC BREAST CARCINOMA·+5
MYLAN INSTITUTI

GEMCITABINE HCL

PYRIMIDINE ANALOGS·METASTATIC BREAST CARCINOMA·+5
APOTEX CORP

GEMCITABINE HCL

PYRIMIDINE ANALOGS·METASTATIC BREAST CARCINOMA·+5
NORTHSTAR RX LL

GEMCITABINE HCL

PYRIMIDINE ANALOGS·METASTATIC BREAST CARCINOMA·+5
MEITHEAL PHARMA

GEMCITABINE HCL

PYRIMIDINE ANALOGS·METASTATIC BREAST CARCINOMA·+5
SAGENT PHARMACE

CISPLATIN

PLATINUM COMPOUNDS·OVARIAN GERM CELL TUMOR CARCINOMA·+5
Hikma Pharmaceuticals USA

CISPLATIN

PLATINUM COMPOUNDS·OVARIAN GERM CELL TUMOR CARCINOMA·+5
WG CRITICAL CAR
Filter & compare in the drug finder →Opens the drug finder with Biliary tract malignancy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Biliary tract malignancy.

Biliary tract malignancy refers to a heterogeneous group of aggressive epithelial cancers affecting the hepatobiliary ductal system, including intrahepatic and extrahepatic cholangiocarcinoma, gallbladder carcinoma, and ampulla of Vater carcinoma.

Pathophysiologically, these malignancies predominantly arise from the epithelial lining of the bile ducts and gallbladder, frequently driven by chronic biliary inflammation, cholestasis, or genetic alterations.

Because early lesions are typically asymptomatic, patients often present at advanced or metastatic stages with clinical features of mechanical biliary obstruction, such as painless jaundice, pruritus, dark urine, acholic stools, abdominal pain, and unexplained weight loss.

Personalize your experience

Follow Biliary tract malignancy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it